Literature DB >> 17206749

Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.

Gary E Wild, Laurie Drozdowski, Carmela Tartaglia, M Tom Clandinin, Alan B R Thomson.   

Abstract

Nutrient deficiencies are common in patients with inflammatory bowel disease (IBD). Both total parenteral and enteral nutrition provide important supportive therapy for IBD patients, but in adults these are not useful for primary therapy. Dietary intervention with omega-3 polyunsaturated fatty acids contained in fish oil may be useful for the care of IBD patients, and recent studies have stressed the role of PPAR on NFkappaB activity on the potential beneficial effect of dietary lipids on intestinal function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206749      PMCID: PMC4065867          DOI: 10.3748/wjg.v13.i1.1

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  105 in total

1.  STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain.

Authors:  Y C Zhou; D J Waxman
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 2.  Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease.

Authors:  Rebecca J Stratton; Trevor R Smith
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

3.  Uptake and metabolism of plasma glutamine by the small intestine.

Authors:  H G Windmueller; A E Spaeth
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

4.  Use of chemically defined diets in the management of patients with acute inflammatory bowel disease.

Authors:  M A Rocchio; C J Cha; K F Haas; H T Randall
Journal:  Am J Surg       Date:  1974-04       Impact factor: 2.565

5.  Role of oral intake in maintenance of gut mass and disaccharide activity.

Authors:  G M Levine; J J Deren; E Steiger; R Zinno
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

Review 6.  Nutrition in inflammatory bowel disease.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

7.  A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

Authors:  C G Su; X Wen; S T Bailey; W Jiang; S M Rangwala; S A Keilbaugh; A Flanigan; S Murthy; M A Lazar; G D Wu
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

Authors:  P Delerive; F Martin-Nizard; G Chinetti; F Trottein; J C Fruchart; J Najib; P Duriez; B Staels
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367

9.  Hyperalimentation in inflammatory bowel disease.

Authors:  J Reilly; J A Ryan; W Strole; J E Fischer
Journal:  Am J Surg       Date:  1976-02       Impact factor: 2.565

10.  Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease.

Authors:  C Axelsson; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

View more
  11 in total

1.  Environmental risk factors for inflammatory bowel disease.

Authors:  Natalie A Molodecky; Gilaad G Kaplan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-05

2.  Regulation of inflammatory and lipid metabolism genes by eicosapentaenoic acid-rich oil.

Authors:  Peter J Gillies; Sujata K Bhatia; Leigh A Belcher; Daniel B Hannon; Jerry T Thompson; John P Vanden Heuvel
Journal:  J Lipid Res       Date:  2012-05-03       Impact factor: 5.922

Review 3.  Immune regulation and anti-cancer activity by lipid inflammatory mediators.

Authors:  Saraswoti Khadge; John Graham Sharp; Timothy R McGuire; Geoffrey M Thiele; Paul Black; Concetta DiRusso; Leah Cook; Lynell W Klassen; James E Talmadge
Journal:  Int Immunopharmacol       Date:  2018-11-14       Impact factor: 4.932

4.  Age and body satisfaction predict diet adherence in adolescents with Inflammatory Bowel Disease.

Authors:  Christina H Vlahou; Lindsey L Cohen; Amanda M Woods; Jeffrey D Lewis; Benjamin D Gold
Journal:  J Clin Psychol Med Settings       Date:  2008-08-21

Review 5.  Advances in nutritional therapy in inflammatory bowel diseases: Review.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Przemysław Tomasik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 6.  Environment and the inflammatory bowel diseases.

Authors:  Alexandra Frolkis; Levinus A Dieleman; Herman W Barkema; Remo Panaccione; Subrata Ghosh; Richard N Fedorak; Karen Madsen; Gilaad G Kaplan
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

Review 7.  Enteral nutrition support to treat malnutrition in inflammatory bowel disease.

Authors:  Roberta Altomare; Giuseppe Damiano; Alida Abruzzo; Vincenzo Davide Palumbo; Giovanni Tomasello; Salvatore Buscemi; Attilio Ignazio Lo Monte
Journal:  Nutrients       Date:  2015-03-25       Impact factor: 5.717

8.  Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis.

Authors:  Liming Liu; Cuiqing Zhao; Ying Yang; Xiaoxia Kong; Tuo Shao; Li Ren; Xinyu Zhuang; Baishuang Yin; Gerald Dryden; Craig McClain; Weimin Luan; Wenke Feng
Journal:  Gastroenterol Res Pract       Date:  2017-05-11       Impact factor: 2.260

9.  Interleukin-6 and Cyclooxygenase-2 downregulation by fatty-acid fractions of Ranunculus constantinopolitanus.

Authors:  Sabreen F Fostok; Rima A Ezzeddine; Fadia R Homaidan; Jamal A Al-Saghir; Ralph G Salloum; Najat A Saliba; Rabih S Talhouk
Journal:  BMC Complement Altern Med       Date:  2009-11-16       Impact factor: 3.659

10.  Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey.

Authors:  Christiane Barthel; Sandra Wiegand; Sylvie Scharl; Michael Scharl; Pascal Frei; Stephan R Vavricka; Michael Fried; Michael Christian Sulz; Nico Wiegand; Gerhard Rogler; Luc Biedermann
Journal:  Nutr J       Date:  2015-08-12       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.